The anti-angiogenic basis of metronomic chemotherapy

作者: Robert S. Kerbel , Barton A. Kamen

DOI: 10.1038/NRC1369

关键词:

摘要: In addition to proliferating cancer cells and various types of normal cells, such as those the bone marrow, conventional cytotoxic chemotherapeutics affect endothelium growing tumour vasculature. The anti-angiogenic efficacy chemotherapy seems be optimized by administering comparatively low doses drug on a frequent or continuous schedule, with no extended interruptions — sometimes referred 'metronomic' chemotherapy. reduced acute toxicity, metronomic increase when administered in combination specific drugs. Gaining better insight into mechanisms these effects could lessen even eliminate empiricism used determine optimal dose schedule for regimens.

参考文章(138)
Kalpna Gupta, Pankaj Gupta, Robert Wild, Sundaram Ramakrishnan, Robert P. Hebbel, Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis. ,vol. 3, pp. 147- 158 ,(1999) , 10.1023/A:1009018702832
Angelo Vacca, Monica Iurlaro, Domenico Ribatti, Monica Minischetti, Beatrice Nico, Roberto Ria, Antonio Pellegrino, Franco Dammacco, Antiangiogenesis Is Produced by Nontoxic Doses of Vinblastine Blood. ,vol. 94, pp. 4143- 4155 ,(1999) , 10.1182/BLOOD.V94.12.4143
Gately S, Kerbel R, Antiangiogenic scheduling of lower dose cancer chemotherapy. Cancer Journal. ,vol. 7, pp. 427- ,(2001)
Greco Fa, Docetaxel (taxotere) administered in weekly schedules Seminars in Oncology. ,vol. 26, pp. 28- 31 ,(1999)
Yoshihiro Kakeji, Beverly A. Teicher, Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents Investigational New Drugs. ,vol. 15, pp. 39- 48 ,(1997) , 10.1023/A:1005718628223
Mirte M. Malingré, Jos H. Beijnen, Jan H.M. Schellens, Oral delivery of taxanes. Investigational New Drugs. ,vol. 19, pp. 155- 162 ,(2001) , 10.1023/A:1010635000879
Yuji Basaki, Kazutaka Miyadera, Yuji Yamada, Kazuhiko Yonekura, Soko Okabe, Konstanty Wierzba, Lumi Chikahisa, Akihiro Hashimoto, UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice. Clinical Cancer Research. ,vol. 5, pp. 2185- 2191 ,(1999)
David Lyden, Koichi Hattori, Sergio Dias, Carla Costa, Pamela Blaikie, Linda Butros, Amy Chadburn, Beate Heissig, Willy Marks, Larry Witte, Yan Wu, Daniel Hicklin, Zhenping Zhu, Neil R. Hackett, Ronald G. Crystal, Malcolm A.S. Moore, Katherine A. Hajjar, Katia Manova, Robert Benezra, Shahin Rafii, Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nature Medicine. ,vol. 7, pp. 1194- 1201 ,(2001) , 10.1038/NM1101-1194
Benilde Jiménez, Olga V. Volpert, Susan E. Crawford, Maria Febbraio, Roy L. Silverstein, Noël Bouck, Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 Nature Medicine. ,vol. 6, pp. 41- 48 ,(2000) , 10.1038/71517
S. Gately, R. Kerbel, Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis. Progress in Experimental Tumor Research. ,vol. 37, pp. 179- 192 ,(2003) , 10.1159/000071373